Clarius Group, LLC - VIR BIOTECHNOLOGY INC ownership

VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 206 filers reported holding VIR BIOTECHNOLOGY INC in Q1 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.2%.

Quarter-by-quarter ownership
Clarius Group, LLC ownership history of VIR BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2023$535,898
-61.8%
57,1930.0%0.05%
-52.8%
Q2 2023$1,402,944
+5.4%
57,1930.0%0.11%
-4.4%
Q1 2023$1,330,881
+91811.7%
57,1930.0%0.11%
-13.1%
Q4 2022$1,448
-99.9%
57,1930.0%0.13%
+18.2%
Q3 2022$1,103,000
+12.0%
57,193
+47.9%
0.11%
+12.2%
Q2 2022$985,000
-44.6%
38,679
-9.0%
0.10%
-30.5%
Q1 2022$1,779,0000.0%42,4840.0%0.14%0.0%
Q4 2021$1,779,000
-4.2%
42,484
-0.4%
0.14%
-15.1%
Q3 2021$1,857,000
+6.3%
42,667
+15.5%
0.17%
+5.7%
Q2 2021$1,747,000
-3.6%
36,945
+4.5%
0.16%
-11.8%
Q1 2021$1,813,00035,3570.18%
Other shareholders
VIR BIOTECHNOLOGY INC shareholders Q1 2022
NameSharesValueWeighting ↓
Bill & Melinda Gates Foundation 1,559,142$36,281,23432.04%
SB INVESTMENT ADVISERS (UK) LTD 18,319,938$426,304,9573.50%
Zebra Capital Management LLC 27,110$6313.15%
Avidity Partners Management LP 1,640,200$38,167,4541.27%
Sofinnova Investments, Inc. 657,559$15,301,3980.98%
DCF Advisers, LLC 62,000$1,442,7400.88%
SECTOR GAMMA AS 145,545$3,386,8320.82%
Temasek Holdings (Private) Ltd 5,814,972$135,314,3980.80%
BRAIDWELL LP 604,036$14,055,9180.46%
SummerHaven Investment Management, LLC 26,045$606,0670.35%
View complete list of VIR BIOTECHNOLOGY INC shareholders